[Management of patients with chronic renal failure].
Terminal renal failure has an incidence of approximately 60 persons per million population, and is on the increase. Victims suffer from an appreciably compromised quality of life and life expectancy. The financial burden on the health service imposed by the need for renal replacement therapy (dialysis or renal transplantation) is considerable. To achieve a therapeutic impact, the underlying kidney disease, as well as the factors driving progression and injury need to be identified as early as possible. Of particular importance in this connection is the rigorous management of arterial hypertension with the use of ACE inhibitors, dietetic measures and normalization of hemoglobin levels.
Lang
D
D
Medizinische Klinik und Poliklinik D, Klinikum der Westfälischen Wilhelms-Universität, Münster.
Kosch
M
M
Schaefer
R M
RM
D015897:Comorbidity; D003928:Diabetic Nephropathies / Q000145:classification / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D018450:Disease Progression; D006801:Humans; D006973:Hypertension / Q000145:classification / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D007676:Kidney Failure, Chronic / Q000145:classification / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D007677:Kidney Function Tests; D017582:Renal Replacement Therapy; D012307:Risk Factors